Author:
Cantin Greg,Liu Qian,Shah Bhavana,Kuhns Scott,Wikström Mats,Cao Shawn,Liu Jennifer
Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. STELARA® (ustekinumab). United States prescribing information. Horsham: Janssen Biotech, Inc.; 2020.
2. Ryan C, Thrash B, Warren RB, Menter A. The use of ustekinumab in autoimmune disease. Expert Opin Biol Ther. 2010;10(4):587–604. https://doi.org/10.1517/14712591003724670.
3. Teng MW, Bowman EP, McElwee JJ, Smyth MJ, Casanova JL, Cooper AM, et al. IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases. Nat Med. 2015;21(7):719–29. https://doi.org/10.1038/nm.3895.
4. European Medicines Agency. EPAR ustekinumab (Stelara), 2019. Available at: https://www.ema.europa.eu/en/medicines/human/EPAR/stelara. Accessed 5 Dec 2022.
5. Markus R, Liu J, Ramchandani M, Landa D, Born T, Kaur P. Developing the totality of evidence for biosimilars: regulatory considerations and building confidence for the healthcare community. BioDrugs. 2017;31(3):175–87. https://doi.org/10.1007/s40259-017-0218-5.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献